BeyondSpring Inc.

10/23/2025 | Press release | Archived content

Phase 2 study of pembrolizumab (Pemb) plus plinabulin (Plin) and…

BeyondSpring Inc. published this content on October 23, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 12, 2026 at 08:28 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]